| Literature DB >> 28776040 |
Tanaporn Wangsanut1, Anup K Ghosh1, Peter G Metzger1, William A Fonzi2, Ronda J Rolfes1.
Abstract
Candida albicans is an opportunistic human fungal pathogen that causes superficial fungal infections and lethal systemic infections. To colonize and establish infections, C. albicans coordinates the expression of virulence and metabolic genes. Previous work showed that the homeodomain transcription factor Grf10 is required for formation of hyphae, a virulence factor. Here we report global gene expression analysis of a grf10Δ strain using a DNA microarray and identify genes for de novo adenylate biosynthesis (ADE genes), one-carbon metabolism, and a nucleoside permease (NUP). Upregulation of these genes in response to adenine limitation required both Grf10 and the myb protein Bas1, as shown by quantitative real-time PCR (qRT-PCR). Phenotypic analysis showed that both mutants exhibited growth defects when grown in the absence of adenine, and the doubling time was slower for the bas1Δ mutant. Bas1 is required for basal expression of these genes, whereas NUP expression is more dependent upon Grf10. Disruption of BAS1 led to only modest defects in hypha formation and weak attenuation of virulence in a systemic mouse model of infection, as opposed to the previously reported strong effects found in the grf10Δ mutant. Our data are consistent with a model in which Grf10 coordinates metabolic effects on nucleotide metabolism by interaction with Bas1 and indicate that AMP biosynthesis and its regulation are important for C. albicans growth and virulence. IMPORTANCECandida albicans is a commensal and a common constituent of the human microbiota; however, it can become pathogenic and cause infections in both immunocompetent and immunocompromised people. C. albicans exhibits remarkable metabolic versatility as it can colonize multiple body sites as a commensal or pathogen. Understanding how C. albicans adapts metabolically to each ecological niche is essential for developing novel therapeutic approaches. Purine metabolism has been targeted pharmaceutically in several diseases; however, the regulation of this pathway has not been fully elucidated in C. albicans. Here, we report how C. albicans controls the AMP de novo biosynthesis pathway in response to purine availability. We show that the lack of the transcription factors Grf10 and Bas1 leads to purine metabolic dysfunction, and this dysfunction affects the ability of C. albicans to establish infections.Entities:
Keywords: Bas1; Candida albicans; Grf10; fungal pathogen; one-carbon metabolism; purine metabolism; transcriptional regulation; virulence
Year: 2017 PMID: 28776040 PMCID: PMC5541157 DOI: 10.1128/mSphere.00161-17
Source DB: PubMed Journal: mSphere ISSN: 2379-5042 Impact factor: 4.389
List of genes that are differentially expressed in the grf10Δ mutant
| Group/GO term | FungiDB ID no. | Gene name | Function | Fold change | |
|---|---|---|---|---|---|
| Downregulated genes | |||||
| Purine metabolism (GO ID no. 6189, 46040, 6188, 72522, 9127) | Adenylosuccinate lyase | −4.14 | 4.48E−7 | ||
| Phosphoribosylaminoimadazole succinocarboxamide synthetase | −3.06 | 4.66E−8 | |||
| 5-Aminoimidazole-4-carboxamide ribotide transformylase | −2.85 | 8.01E−7 | |||
| Phosphoribosylamine-glycine ligase and phosphoribosylformylglycinamidine cyclo-ligase | −2.50 | 1.91E−6 | |||
| Phosphoribosylaminoimadazole carboxylase | −2.28 | 6.97E−6 | |||
| 5-Phosphoribosylformyl glycinamidine synthetase | −1.97 | 9.74E−6 | |||
| One-carbon metabolism | Cytoplasmic serine hydroxymethyltransferase | −3.48 | 1.50E−8 | ||
| Ortholog(s) has phosphoserine phosphatase activity | −2.48 | 4.58E−6 | |||
| Ortholog(s) has methylenetetrahydrofolate dehydrogenase (NAD+) activity | −3.52 | 1.36E−6 | |||
| Protein similar to | −3.69 | 5.00E−8 | |||
| Predicted formate dehydrogenase | −4.51 | 8.99E−8 | |||
| Iron metabolism | C terminus similar to ferric reductases | −3.89 | 1.12E−8 | ||
| Ferric reductase | −3.02 | 1.09E−6 | |||
| Transcription | Zn(II)2 Cys6 transcription factor; involved in control of glycolysis | −2.03 | 4.66E−6 | ||
| Miscellaneous | Putative β4 subunit of 20S proteasome | −40.42 | 1.23E−10 | ||
| −12.76 | 1.47E−8 | ||||
| Nucleoside permease; transports adenosine and guanosine | −7.15 | 1.65E−8 | |||
| Putative xylulokinase | −5.29 | 8.37E−9 | |||
| Putative riboflavin (vitamin B2) synthase | −4.48 | 7.32E−8 | |||
| Protein of unknown function | −4.24 | 3.89E−8 | |||
| Uncharacterized | −2.96 | 2.15E−7 | |||
| Predicted vacuolar protein | −2.62 | 4.46E−7 | |||
| Putative actin-interacting protein; | −2.41 | 8.58E−8 | |||
| Ortholog(s) involved in initiation of DNA replication | −2.16 | 2.97E−7 | |||
| Protein of unknown function | −2.10 | 2.54E−6 | |||
| Upregulated genes | |||||
| Cell adhesion and biofilm formation (GO ID no. 7155, 22610, 42710, 44011, 51703) | White-phase yeast transcript | 10.64 | 1.07E−8 | ||
| Heat shock protein | 3.85 | 1.48E−7 | |||
| Putative heat shock protein | 3.64 | 1.88E−7 | |||
| ALS family protein; role in adhesion and biofilm formation | 3.64 | 1.70E−6 | |||
| Glycosylphosphatidylinositol-anchored adhesin; roles in adhesion and germ tube induction | 3.47 | 2.37E−7 | |||
| Glycerol 3-phosphatase; roles in osmotic tolerance | 3.11 | 3.16E−6 | |||
| Putative antibiotic resistance transporter | 2.19 | 1.34E−5 | |||
| Aldo-keto reductase; role in fibronectin adhesion and cell surface hydrophobicity | 2.11 | 2.51E−5 | |||
| Adhesin-like protein | 2.35 | 2.15E−6 | |||
| GPI-anchored adhesin-like protein of cell wall; role in cell wall integrity | 2.00 | 2.36E−6 | |||
| Miscellaneous | Putative ribonucleoside-diphosphate reductase | 4.27 | 1.10E−7 | ||
| Cell wall protein, stationary-phase enriched, GlcNAc-induced | 3.58 | 9.37E−8 | |||
| Uncharacterized | 3.23 | 9.14E−8 | |||
| Aromatic decarboxylase; catabolic alcohol synthesis | 3.04 | 1.65E−7 | |||
| Protein of unknown function | 3.00 | 1.25E−6 | |||
| Predicted Rho guanyl-nucleotide exchange factor activity | 2.69 | 1.34E−5 | |||
| Adenylyl cyclase and stress-responsive protein | 2.50 | 4.13E−8 | |||
| α-1,2-Mannosyltransferase | 2.50 | 2.30E−7 | |||
| NADPH oxidoreductase | 2.49 | 1.30E−6 | |||
| Possible stress protein | 2.36 | 1.51E−5 | |||
| Glutathione-independent glyoxalase | 2.36 | 2.52E−6 | |||
| Ortholog of | 2.32 | 1.22E−5 | |||
| Protein of unknown function | 2.24 | 1.38E−6 | |||
| 2-Hydroxyacid dehydrogenase domain-containing protein | 2.20 | 2.85E−5 | |||
| Putative mitochondrial respiratory protein | 2.19 | 2.69E−6 | |||
| Possibly involved in retrograde transport between Golgi apparatus and endoplasmic reticulum | 2.01 | 3.78E−6 | |||
| Protein of unknown function; induced in core stress response | 2.01 | 1.06E−5 | |||
| Putative xylose and arabinose reductase | 2.00 | 5.98E−7 | |||
| Putative protease B inhibitor | 2.00 | 3.17E−6 | |||
| Putative protein of unknown function; Hap43p-repressed gene | 2.00 | 1.04E−5 | |||
| 2.00 | 1.54E−5 | ||||
FIG 1 The purine salvage, AMP de novo biosynthesis, and one-carbon metabolic pathways of C. albicans. Genes identified by microarray analysis are circled in red. Enzymes and the genes encoding them that catalyze de novo purine biosynthesis and salvage pathways are as follows (from top to bottom): glutamine phosphoribosylpyrophosphate amidotransferase, ADE4; glycinamide ribotide synthase, ADE5; glycinamide ribotide transformylase, ADE8; formylglycinamide synthase, ADE6; aminoimidazole ribotide synthase, ADE7; aminoimidazole ribotide carboxylase, ADE2; succinylaminoimidazolecarboxamide ribotide synthase, ADE1; adenylosuccinate lyase, ADE13; aminoimidazole carboxamide ribotide transformylase and IMP cyclohydrolase, ADE17; adenylosuccinate synthase, ADE12; and nucleoside permease, NUP. Enzymes catalyzing the reactions in one-carbon metabolism and the genes that encode them are as follows: serine hydroxymethyltransferase, SHM2; NAD+-dependent 5,10-methylenetetrahydrafolate dehydrogenase, MTD1; mitochondrial C1-tetrahydrofolate synthase, ADE3 (MIS11). Intermediate metabolites are abbreviated as follows (from top to bottom): PRPP, 5-phosphoribosyl-α-1-pyrophosphate; PRA, 5-phospho-β-d-ribosylamine; GAR, 5-phosphoribosyl-glycinamide; FGAR, 5′-phosphoribosyl-N-formylglycinamide; FGAM, 5′-phosphoribosyl-N-formylglycinamidine; AIR, 5′-phosphoribosyl-5-aminoimidazole; CAIR, 5′-phosphoribosyl-5-amino-imidazole-4-carboxylate; SAICAR, 5-amino-4-imidazole-N-succinocarboxamide ribonucleotide; AICAR, 5-amino-4-imidazolecarboxamide ribonucleotide; FAICAR, 5′-phosphoribosyl-4-carboxamide-5-formamidoimidazole; IMP, inosine monophosphate; SAMP, adenylosuccinate; THF, tetrahydrofolate.
FIG 2 The bas1Δ and grf10Δ mutants exhibit leaky adenine auxotrophy. (A) The wild-type (DAY286), BAS1 heterozygote (RAC105), bas1Δ (RAC108), and BAS1 complemented (RAC111) strains and GRF10 heterozygote (RAC114), grf10Δ (RAC117), and GRF10 complemented (RAC120) strains from C. albicans in the BWP17 background were grown overnight in YPD medium and were spotted at a starting OD600 of 0.1 on plates containing SC agar medium with (+Ade) or without (−Ade) adenine. The plates were incubated for 48 h at 30°C. (B) The wild-type strain (OHWT), bas1Δ (TF016) and grf10Δ (TF021) mutant strains, and complemented (BAS1R and GRF10R) strains in the SN152 background were grown under the same conditions as in panel A.
FIG 3 Grf10 is not required for growth under phosphate limitation in C. albicans. The C. albicans wild-type (OHWT) and grf10Δ (TF021Δ) and pho4Δ (TF004Δ) mutant strains and the control S. cerevisiae wild-type and pho2Δ and pho4Δ mutant strains were grown overnight in YPD medium and streaked out for single colonies on YPD medium with adenine containing or lacking (−Pi) inorganic phosphate for 2 days at 30°C.
Doubling times for the wild-type and bas1Δ and grf10Δ mutant strains
| Strain | Doubling time (min) | Ratio | |
|---|---|---|---|
| +Ade | −Ade | ||
| DAY286 (WT) | 107 ± 1 | 104 ± 4 | 0.97 |
| 106 ± 1 | 103 ± 1 | 0.97 | |
| 107 ± 1 | 202 ± 6 | 1.89 | |
| 109 ± 4 | 140 ± 2 | 1.28 | |
| 108 ± 1 | 103 ± 1 | 0.95 | |
| 104 ± 2 | 118 ± 1 | 1.13 | |
| 104 ± 2 | 103 ± 4 | 0.99 | |
| OHWT (WT) | 107 ± 2 | 106 ± 1 | 0.99 |
| 110 ± 2 | 217 ± 5 | 1.97 | |
| 106 ± 2 | 143 ± 1 | 1.35 | |
| 107 ± 4 | 118 ± 2 | 1.10 | |
| 107 ± 2 | 106 ± 3 | 0.99 | |
FIG 4 The expression of the ADE regulon is strongly downregulated in the bas1Δ and grf10Δ mutants. The wild-type strain (DAY286) and bas1Δ (RAC108) and grf10Δ (RAC117) mutant strains were grown in SC+Ade and shifted into media containing (+Ade) or lacking (−Ade) adenine; cells were harvested and RNA was prepared (see Materials and Methods for details). Relative gene expression was calculated by the ΔC method using TEF1 as the reference gene. Expression was normalized to the wild-type strain under repressing (+Ade) conditions; this value is 0, but is depicted here as 0.1 for visualization (yellow bars). Elevated expression from the derepressed wild-type strain (−Ade) is shown as red bars; repressed and depressed expression levels from the bas1Δ mutant are shown in light green and dark green, respectively, and those for the grf10Δ mutant are shown in light blue and dark blue, respectively. Error bars indicate the standard deviation.
Yeast strains used in this study
| Strain | Relevant genotype | Reference or source |
|---|---|---|
| BWP17 | ||
| DAY185 | ||
| DAY286 | ||
| RAC105 | This study | |
| RAC108 | This study | |
| RAC111 | This study | |
| RAC114 | ||
| RAC117 | ||
| RAC120 | ||
| SN152 | ||
| OHWT | ||
| TF016 | ||
| RAC255 | This study | |
| TF021 | ||
| RAC256 | This study | |
| TF004 |
FIG 5 The expression of one-carbon metabolic genes and the expression of nucleoside permease are differentially regulated by Bas1 and Grf10. Strains were grown, RNA was prepared, and gene expression was analyzed as described in the legend to Fig. 4. The bars are color-coded as in Fig. 4. (A) Genes in the one-carbon metabolic pathway. (B) Expression of nucleoside permease. Error bars indicate the standard deviation.
FIG 6 Disruption of BAS1 mildly affects hyphal formation. To induce hyphae, wild-type and bas1Δ mutant strains were grown overnight in YPD medium and washed twice with sterile water. Cell densities were adjusted to 2 × 107 CFU/ml, 5 µl of each strain was spotted onto YPD+10% serum, M-199, and Spider solid media, and plates were incubated for 3 days at 37°C and photographed. The induction of hyphae was performed at least three times, and representative examples are shown for each strain. Size bars, 500 μm.
FIG 7 The bas1Δ mutant is less virulent in a mouse model of infection. Mice were infected with 1 × 106 cells of a wild-type strain (DAY185) or with the heterozygous and homozygous null BAS1 mutants through the lateral tail vein, and survival was monitored for up to 15 days postinfection. Shown is survival of mice infected with wild-type strain DAY185 (solid circles), the heterozygote strain RAC105 (open circles), the homozygous null mutant RAC108 (open triangles), or the restored strain RAC111 (open squares). Difference from DAY185 is significant for RAC108 (P = 7.53 × 10−6) but not significant for RAC105 and RAC111 (P > 0.05).
Primers used in this study
| Name | Description | Sequence (5′→3′) |
|---|---|---|
| BAS1-5DR | CCAAATCCTCTGATGGTTTTATGCAACCCAGATTATTTTAGCATTCTAACTCGTATCAGCgttttcccagtcacgacgtt | |
| BAS1-3DR | ACTACAATCAATCATCGTATATTCTTACATTAGCATCTGATTCTTATACACTAGAATACCtgtggaattgtgagcggata | |
| BAS1-DF | Diagnostic forward primer | GTGAAGTTTCTGATGCGAC |
| BAS1-DR | Diagnostic reverse primer | GCCAAGGGACCTATTTGC |
| B1RF | Restored allele forward primer | CTGGATCCATTGGCAGCATTATTG |
| B1RR | Restored allele reverse primer | ACGGATCCACGCCTTAACCAACT |
| G10RF | Restored allele forward primer | AGTGGGCCCCTTAGTATTCAACGA |
| G10RR | Restored allele reverse primer | TGAGGGCCCGTATCATGACTTTG |
| Forward primer | GAGACTATGCTGCTACTAAAGG | |
| Reverse primer | CAACACTTCGTCAACAAGAAC | |
| Forward primer | CGATTCGGATCTACCAGTTATG | |
| Reverse primer | GGAGTTCTGTGTGCACTTAC | |
| Forward primer | GTTGCCATGGCTAGAGAAG | |
| Reverse primer | TGGTGTCAGCTAAATCAATCC | |
| Forward primer | CTCATATTACTGGTGGAGGATTAG | |
| Reverse primer | ATCTCTGGTACTTGCCATTG | |
| Forward primer | GCAGCTGATATCCCTTCATTAG | |
| Reverse primer | TCCATACCAATGGCTTGAA | |
| Forward primer | CTTTGGAGAAGGCAGGAATC | |
| Reverse primer | CTCCATCTTGACCAGCTTTC | |
| Forward primer | GGTCCATTCCCAACAGAAC | |
| Reverse primer | ATCCAACCAACCACATCTTC | |
| Forward primer | ACAAGAAGGTGGCGATAATG | |
| Reverse primer | GTTTGTTGAGGAGCTCTACC | |
| Forward primer | AACAAGGTGCTGTTGATTTG | |
| Reverse primer | CTCCTAAGCCGATAACCATAC | |
| Forward primer | TGTCCCATCCATTGGTAAAG | |
| Reverse primer | AAGAGGTCGCATCAGAAAC | |
| Forward primer | CAAATTGATGGTGCTAGAGTTG | |
| Reverse primer | CTAACTCCACCTGGAACTAAAG | |
| Forward primer | AATGTATGGTGCTGGTGAAG | |
| Reverse primer | GTCTTGGCGATACAGATTGG | |
| Forward primer | GACCACCTCCATCAATGTC | |
| Reverse primer | TTGGAGTACCAGCAATAACC | |
| Forward primer | TTCGTCAAATCCGGTGATG | |
| Reverse primer | CTGACAGCGAATCTACCTAATG |
Lowercase represents the nucleotides that anneal with the vector.